Sarissa Capital Management LP Long-Term Concentrated

CIK: 0001577524 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: Feb 16, 2021

Total Value ($000): $979,780 (100.0% shares, 0.0% debt)

Holdings (12)

IRWD IRONWOOD PHARMACEUTICALS INC 16.3%

Value ($000) $159,915 Shares 14,040,000 Est. Cost $11.68 Unrealized -6.3%

ALKS ALKERMES PLC 16.2%

Value ($000) $158,602 Shares 7,950,000 Est. Cost $18.70 Unrealized -2.3%

BIIB BIOGEN INC 16.1%

Value ($000) $157,444 Shares 643,000 Est. Cost $278.12 Unrealized -6.8%

JAZZ JAZZ PHARMACEUTICALS PLC 15.6%

Value ($000) $153,182 Shares 928,100 Est. Cost $128.37 Unrealized +16.0%

— ALEXION PHARMACEUTICALS INC 12.7%

Value ($000) $124,638 Shares 797,740 Est. Cost $108.59 Unrealized —

INVA INNOVIVA INC 8.1%

Value ($000) $79,469 Shares 6,414,000 Est. Cost $13.01 Unrealized -17.1%

— MERSANA THERAPEUTICS INC 7.9%

Value ($000) $77,887 Shares 2,927,000 Est. Cost $7.14 Unrealized —

BCRX BioCryst Pharmaceuticals Inc 6.2%

Value ($000) $60,903 Shares 8,175,000 Est. Cost $4.60 Unrealized +12.1%

— SARISSA CAPITAL ACQUISITN CO 0.5%

Value ($000) $4,999 Shares 3,333,333 Est. Cost $1.50 Unrealized —

— REGULUS THERAPEUTICS INC 0.3%

Value ($000) $2,499 Shares 1,851,851 Est. Cost $1.25 Unrealized —

— MIRATI THERAPEUTICS INC 0.0%

Value ($000) $219 Shares 1,000 Est. Cost $42.00 Unrealized —

— INTERCEPT PHARMACEUTICALS INC 0.0%

Value ($000) $23 Shares 950 Est. Cost $79.88 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
IRWD	IRONWOOD PHARMACEUTICALS INC	14,040,000	$159,915	16.3%	$11.68	-6.3%	COM CL A	46333X108
ALKS	ALKERMES PLC	7,950,000	$158,602	16.2%	$18.70	-2.3%	SHS	G01767105
BIIB	BIOGEN INC	643,000	$157,444	16.1%	$278.12	-6.8%	COM	09062X103
JAZZ	JAZZ PHARMACEUTICALS PLC	928,100	$153,182	15.6%	$128.37	+16.0%	SHS USD	G50871105
—	ALEXION PHARMACEUTICALS INC	797,740	$124,638	12.7%	$108.59	—	COM	015351109
INVA	INNOVIVA INC	6,414,000	$79,469	8.1%	$13.01	-17.1%	COM	45781M101
—	MERSANA THERAPEUTICS INC	2,927,000	$77,887	7.9%	$7.14	—	COM	59045L106
BCRX	BioCryst Pharmaceuticals Inc	8,175,000	$60,903	6.2%	$4.60	+12.1%	COM	09058V103
—	SARISSA CAPITAL ACQUISITN CO	3,333,333	$4,999	0.5%	$1.50	—	W EXP 10/23/202	G7823W110
—	REGULUS THERAPEUTICS INC	1,851,851	$2,499	0.3%	$1.25	—	COM NEW	75915K200
—	MIRATI THERAPEUTICS INC	1,000	$219	0.0%	$42.00	—	COM	60468T105
—	INTERCEPT PHARMACEUTICALS INC	950	$23	0.0%	$79.88	—	COM	45845P108